Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WPE
|
|||
| Former ID |
DCL000798
|
|||
| Drug Name |
Epothilon
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56] | Phase 3 | [1] | |
| Company |
Bayer AG
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tubulin (TUB) | Target Info | Stablizer | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for ovarian cancer. Expert Opin Emerg Drugs. 2008 Sep;13(3):523-36. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.